Cannabinoids and COVID-19

Cannabinoids and COVID-19

Myriam El Biali, Barbara Broers, Marie Besson, Jules Demeules

Since the endocannabinoid system is involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the COVID 19 pandemia. Some data suggest that the immunomodulatory effect of cannabinoids may affect the course and severity of SARS-CoV-2 infection. Given the large number of cannabinoids consumers in the community, this commentary presents the current knowledge on the potential impact of cannabinoids and endocannabinoids on bacterial and viral infection courses namely SARS-CoV-2 disease. Practical recommendations, which can be drawn from the literature, are given.

2020

immunity, covid-19, SARS-CoV-2, endocannabinoid system, cannabinoids

10.1159/000510799

Epidemiology and Health

Korean Society of Epidemiology

Medicine